GlassScriptPhysician profile
Jesus Macrohon
NPI 1770189656
$831.60
in general payments reported to CMS, 2019-2025
18 companies · $91.36 in 2025
The $91.36 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $249 · 2023: $228 · 2024: $263 · 2025: $91.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $583.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $582.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $195.65 | 2022-2024 | Airsupra, Farxiga |
| Glaxosmithkline, LLC. | $116.76 | 2023 | Trelegy Ellipta |
| Urovant Sciences INC | $105.02 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $55.58 | 2022-2024 | Abilify Maintena, Abilify Asimtufii |
| Neurelis, INC. | $49.76 | 2023 | Valtoco |
| Idorsia Pharmaceuticals US INC | $48.91 | 2023-2024 | Quviviq |
| Novo Nordisk INC | $45.39 | 2024-2025 | Ozempic, Rybelsus |
| Corcept Therapeutics | $34.99 | 2022-2025 | Korlym |
| Actelion Pharmaceuticals US, INC. | $24.12 | 2024 | Opsumit, Uptravi |
| Exact Sciences Corporation | $20.74 | 2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $19.93 | 2025 | Mounjaro, Zepbound |
| Dexcom, INC. | $18.36 | 2024 | Dexcom G6 Transmitter |
| Teva Pharmaceuticals USA, INC. | $18.33 | 2025 | Austedo Xr |
| Biohaven Pharmaceutical Holding Company LTD. | $17.98 | 2022 | |
| Neurocrine Biosciences, INC. | $16.39 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $15.51 | 2022 | |
| Paratek Pharmaceuticals, INC. | $15.48 | 2022 | |
| Si-Bone, INC. | $12.70 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesus Macrohon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.